Dan Brennan
Stock Analyst at TD Cowen
(3.84)
# 604
Out of 4,902 analysts
108
Total ratings
48.28%
Success rate
10.37%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Buy | $32 | $31.29 | +2.29% | 1 | Jul 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $60 | $47.28 | +26.90% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $80.42 | +36.78% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.51 | -0.40% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $60.65 | +22.01% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $52.21 | +64.72% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $143.38 | +22.05% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $156.70 | +59.54% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $42.19 | +65.92% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $97.93 | +80.74% | 12 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $95.58 | +50.66% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $296.92 | +38.08% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $194.79 | +61.71% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $116.36 | +37.50% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $4.82 | +522.41% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $13.29 | +133.26% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $424.98 | +54.83% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $40.95 | +24.54% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.31 | +801.48% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $6.72 | +197.62% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $12.45 | +157.03% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $233.31 | +134.02% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.27 | +208.37% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.39 | +979.14% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $146.88 | +57.95% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,205.68 | -27.01% | 3 | Oct 7, 2020 |
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $31.29
Upside: +2.29%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $47.28
Upside: +26.90%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $80.42
Upside: +36.78%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.51
Upside: -0.40%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $60.65
Upside: +22.01%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $52.21
Upside: +64.72%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $143.38
Upside: +22.05%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $156.70
Upside: +59.54%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $42.19
Upside: +65.92%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $97.93
Upside: +80.74%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $95.58
Upside: +50.66%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $296.92
Upside: +38.08%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $194.79
Upside: +61.71%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $116.36
Upside: +37.50%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $4.82
Upside: +522.41%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $13.29
Upside: +133.26%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $424.98
Upside: +54.83%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $40.95
Upside: +24.54%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.31
Upside: +801.48%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $6.72
Upside: +197.62%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $12.45
Upside: +157.03%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $233.31
Upside: +134.02%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $2.27
Upside: +208.37%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.39
Upside: +979.14%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $146.88
Upside: +57.95%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,205.68
Upside: -27.01%